Zobrazeno 1 - 10
of 669
pro vyhledávání: '"Laurence Klotz"'
Autor:
Laurence Klotz, Tri Tat
Publikováno v:
BJUI Compass, Vol 5, Iss 3, Pp 392-402 (2024)
Abstract Objective The objective of the study is to evaluate whether low nadir testosterone during treatment with triptorelin pamoate, a luteinising hormone‐releasing hormone (LHRH) agonist, is associated with improved clinical outcomes in patients
Externí odkaz:
https://doaj.org/article/268a0cf19c654584a4c9d127118e9287
Publikováno v:
Société Internationale d’Urologie Journal, Vol 3, Iss 4, Pp 259-275 (2022)
PurposeSubstantial evidence indicates that men with prostate cancer are at an increased risk for cardiovascular disease, and medical and surgical androgen deprivation therapy is associated with further increased cardiovascular risk. There are conflic
Externí odkaz:
https://doaj.org/article/88c4818241d1433c9b25ae6629c3d6b2
Autor:
Sebastiaan Remmers, Jozien Helleman, Daan Nieboer, Bruce Trock, Matthew E. Hyndman, Caroline M. Moore, Vincent Gnanapragasam, Lui Shiong Lee, Oussama Elhage, Laurence Klotz, Peter Carroll, Tom Pickles, Anders Bjartell, Grégoire Robert, Mark Frydenberg, Mikio Sugimoto, Behfar Ehdaie, Todd M. Morgan, Jose Rubio-Briones, Axel Semjonow, Chris H. Bangma, Monique J. Roobol
Publikováno v:
European Urology Open Science, Vol 41, Iss , Pp 126-133 (2022)
Background: Active surveillance (AS) is a management option for men diagnosed with low-risk prostate cancer. Opinions differ on whether it is safe to include young men (≤60 yr) or men with intermediate-risk disease. Objective: To assess whether rea
Externí odkaz:
https://doaj.org/article/a460e28542014822b7a8ac0483ebc3c7
Autor:
Hannes Cash, Sebastian Hofbauer, Neal Shore, Christian P. Pavlovich, Stephan Bulang, Martin Schostak, Erik Planken, Joris J. Jaspars, Ferdinand Luger, Laurence Klotz, Georg Salomon
Publikováno v:
Société Internationale d’Urologie Journal, Vol 3, Iss 2, Pp 62-68 (2022)
ObjectiveMicro-ultrasound is an imaging modality used to visualize and target prostate cancer during transrectal or transperineal biopsy. We evaluated the effectiveness of a micro-ultrasound training program and estimated the learning curve for prost
Externí odkaz:
https://doaj.org/article/87fb3491f32a4962ad8096638b37f873
Autor:
Christian Pavlovich, Laurence Klotz
Publikováno v:
Société Internationale d’Urologie Journal, Vol 3, Iss 1, Pp 8-13 (2022)
Objectives: To compare the performance of micro-ultrasound (mUS) with multi-parametric magnetic resonance imaging (mpMRI) in detecting clinically significant prostate cancer. Materials and Methods: Retrospective data from consecutive patients with a
Externí odkaz:
https://doaj.org/article/d57e99c2fa994b71b862b05d185f7b3f
Autor:
Veeru Kasivisvanathan, Vinson Wai-Shun Chan, Keiran D Clement, Brooke Levis, Masoom Haider, Ridhi Agarwal, Mark Emberton, Gregory R Pond, Yemisi Takwoingi, Laurence Klotz, Caroline M Moore, VISION study collaborators
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263345 (2022)
BackgroundTransrectal ultrasound (TRUS) guided biopsy for prostate cancer is prone to random and systemic error and has been shown to have a negative predictive value of 70%. PRECISION and PRECISE are among the first randomised studies to evaluate th
Externí odkaz:
https://doaj.org/article/69cef101b5e942828eb946bdde8574fb
Autor:
Laurence Klotz
Publikováno v:
Asian Journal of Urology, Vol 6, Iss 2, Pp 146-152 (2019)
The approach to favorable risk prostate cancer known as “active surveillance” was first described explicitly in 2002. This was a report of 250 patients managed with a strategy of expectant management, with serial prostate-specific antigen and per
Externí odkaz:
https://doaj.org/article/35b08e19be464e59899e67ce9bced563
Autor:
Mélanie Rouleau, Francis Lemire, Michel Déry, Benoît Thériault, Gabriel Dubois, Yves Fradet, Paul Toren, Chantal Guillemette, Louis Lacombe, Laurence Klotz, Fred Saad, Dominique Guérette, Frédéric Pouliot
Publikováno v:
Endocrine Connections, Vol 8, Iss 2, Pp 132-140 (2019)
Failure to suppress testosterone below 0.7 nM in castrated prostate cancer patients is associated with poor clinical outcomes. Testosterone levels in castrated patients are therefore routinely measured. Although mass spectrometry is the gold standard
Externí odkaz:
https://doaj.org/article/ea517c020bd848f692fd3c16a0063d49
Autor:
Véronique Ouellet, Armen Aprikian, Alain Bergeron, Fadi Brimo, Robert G. Bristow, Simone Chevalier, Darrel Drachenberg, Ladan Fazli, Neil E. Fleshner, Martin Gleave, Pierre Karakiewicz, Laurence Klotz, Louis Lacombe, Jean-Baptiste Lattouf, Theodorus van der Kwast, Jeremy A. Squire, Mathieu Latour, Dominique Trudel, Anne-Marie Mes-Masson, Fred Saad
Publikováno v:
BMC Urology, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Refinement of parameters defining prostate cancer (PC) prognosis are urgently needed to identify patients with indolent versus aggressive disease. The Canadian Prostate Cancer Biomaker Network (CPCBN) consists of researchers from
Externí odkaz:
https://doaj.org/article/925f32af011249508d5bb084d1f7c820
Publikováno v:
European Medical Journal Urology, Vol 2, Iss 1, Pp 48-53 (2014)
This symposium was focused on reviewing androgen deprivation therapy (ADT) in prostate cancer, highlighting the implications of this therapy in clinical practice and including a focus on the cardiovascular (CV) risk associated with ADT therapy.
Externí odkaz:
https://doaj.org/article/71f778deeb824448a7a9a533a76d8694